Pharma HUB And Patient Access Support Service Market To Reach $5.7 Billion By 2030

Pharma HUB And Patient Access Support Service Market Growth & Trends

The global pharma HUB and patient access support service market size is expected to reach USD 5.7 billion by 2030, registering a CAGR of 9.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth is attributed to the significant prevalence of rare and orphan-diseased patients requiring access to specific medicines. Furthermore, the market is driven by an emphasis on establishing a patient-centered ecosystem to provide extensive support to patients throughout their treatment and an increasing demand for tailored solutions aimed at improving patient outcomes.

The prevalence of rare diseases has fueled growth in the pharmaceutical hub and patient access support service market. It is driven by specialized treatment demand, incentives for orphan drug development, the need for patient access support due to rarity, global collaborative efforts, and an expanding market for rare disease treatments. These factors have led to increased investment, innovation, and collaboration in the pharmaceutical industry, particularly in areas related to rare disease research, development, and patient support services.

Up to 36 million people in the EU are affected by rare diseases, which encompass over 6,000 distinct conditions. While some rare diseases impact only a few patients, others can affect as many as 245,000 individuals. About 80% of these diseases have genetic roots, with 70% beginning in childhood. Furthermore, in the U.S., over 10,000 rare diseases impact more than 30 million people. Moreover, it's estimated that 6-8% of the population in India is affected by rare or ultra-rare diseases. Hence, the significant prevalence of rare diseases is expected to contribute to the market growth.

Pharmaceutical companies are prioritizing the needs of patients by creating a patient-centric ecosystem that offers services to support them throughout their therapy journey. This is due to various factors such as lack of proper training, medication non-adherence, and fear of adverse effects, or missed appointments, which can affect a patient's treatment. Patients can access relevant patient service resources and start engaging with the organization as soon as they are prescribed a particular therapy.

With advanced analytics and AI technology, patient services teams can now obtain actionable insights to cater to each patient's individual needs as they progress through their treatment journey. This tailored approach ensures that patients receive the right support at the right time, leading to better therapy outcomes. For instance, companies such as Managed Markets Insight & Technology, LLC, IQVIA, & IntegriChain are offering such solutions in order to overcome barriers to patient access.

Furthermore, the life sciences industry is adapting to the digital era by focusing on value-based care and outcome-driven models that prioritize integrated services. This shift has led to the adoption of technological advancements in integrated solutions to enhance patient access and improve healthcare outcomes. One such example is the PatientLink platform, a new enterprise SaaS by TrialCard. Launched in April 2022, PatientLink simplifies patient access and engagement with Patient Support Programs while improving adherence to medication. It is a highly configurable service that offers an omnichannel experience, enabling leaders in life sciences to meet the needs of a demanding healthcare marketplace through multi-system interoperability.

 Request a free sample copy or view report summary: Pharma HUB And Patient Access Support Service Market Report

Pharma HUB And Patient Access Support Service Market Report Highlights

• Based on service type, the program enrollment segment held the largest market share in 2023. Its growth can be attributed to growing demand for customized solutions and the increasing need to improve patient outcomes drive

• Based on service delivery type, the integrated services segment held the largest market share in 2023. Its dominance is because the integrated solutions offer a unified platform to manage various functions such as patient access support, reimbursement assistance, and pharmacy coordination

• North America dominated the global market with the largest revenue share in 2023. Its growth can be attributed to the rising prevalence of lifestyle-associated diseases, such as diabetes & cardiovascular disorders, growing number of clinical trial-based research, strong presence of market players in the region, and presence of developed countries, such as the U.S.

Pharma HUB And Patient Access Support Service Market Segmentation

Grand View Research has segmented the global pharma HUB and patient access support service market based on service type, service delivery type, and region:

Pharma HUB And Patient Access Support Service Type Outlook (Revenue, USD Million, 2018 - 2030)

• Program Enrollment

  • Order processing

  • Application processing

  • Ease of enrollment (through phone, face, portal, or app)

  • Program data

• Treatment Navigators

  • Process flows and standard operating procedures

  • Program literature and scripts

  • Care team training

  • Systems testing and optimization

• Reimbursement Services/Affordability Services

• Clinical Educator

• Coordination of Specialty Pharmacy/Dispensing

• Others

Pharma HUB And Patient Access Support Service Delivery Type Outlook (Revenue, USD Million, 2018 - 2030)

• Integrated Services

• Standalone Services

Pharma HUB And Patient Access Support Service Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Pharma HUB And Patient Access Support Service Market

• PharmaCord

• Fortrea

• AssistRx

• CareMetx

• ConnectiveRx

• Lash Group

• McKesson

• Inizio Engage

• NS Pharma, Inc. (a wholly owned subsidiary of Nippon Shinyaku Co., Ltd.)

• Sonexus Health (acquired by Cardinal Health)

• Envoy Health Management, LLC (independently operated subsidiary of Diplomat Pharmacy, Inc.)

• EVERSANA

• United BioSource LLC (UBC)

• Mercalis